LEONNA WHITE: Open Payments
NPI 1275094385 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,991 in 88 payments from 18 companies in 2025. Trend: 2023 $2,380 · 2024 $2,836 · 2025 $1,991
Food & beverage: $1,991
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $351 |
| Phathom Pharmaceuticals, Inc. | 9 | $252 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $237 |
| Ardelyx, Inc. | 9 | $212 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $195 |
| Gilead Sciences, Inc. | 7 | $149 |
| Janssen Biotech, Inc. | 6 | $117 |
| Lilly USA, LLC | 5 | $107 |
| Madrigal Pharmaceuticals | 3 | $83 |
| Intercept Pharmaceuticals, Inc. | 3 | $68 |
Products named: VOQUEZNA, IBSRELA, XIFAXAN, ENTYVIO, RINVOQ, TREMFYA, OMVOH, REZDIFFRA.
Industry payments across CT — which companies pay providers there.
